|
⚲
|
| Keyboard |
| Gordonmd Global Investments LP
✚
|
|
|---|---|
| CRD # | 316751 |
| SEC # | 801-128434 |
| CIK # | 0002039349 |
| AUM | 322.3 M (2026-03-26) |
| Employees | 7 (71% Investors, 0% Brokers) |
| Phone | 213-304-6199 |
| Address | 9460 Wilshire Blvd Beverly Hills, CA 90212 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002039349 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Teva Pharmaceutical Industries Ltd | 37.9 | ||
| Kyverna Therapeutics Inc | 36.6 | ||
| VIR Biotechnology Inc | 13.6 | ||
| Bausch & LOMB Corp | 9.1 | ||
| Amgen Inc | 7.1 | ||
| Scholar Rock Holding Corp | 6.5 | ||
| Ultragenyx Pharmaceutical Inc | 6.1 | ||
| Pyxis Oncology Inc | 6.0 | ||
| Sionna Therapeutics Inc | 5.5 | ||
| Celldex Therapeutics Inc | 5.4 | ||
| Insmed Inc | 4.7 | ||
| Crinetics Pharmaceuticals Inc | 4.6 | ||
| Incyte Corp | 4.1 | ||
| Allogene Therapeutics Inc | 3.5 | ||
| Taysha Gene Therapies Inc | 3.3 | ||
| Tarsus Pharmaceuticals Inc | 3.0 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| PE | Gordonmd SPV I LLC | [2026-03-26] | 22.5 M | 5.0 M |
| Filed 2025-09-25 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| PE | Gordonmd PE Fund II LP | [2025-03-25] | 26.6 M | 19.3 M |
| Filed 2025-10-03 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Revenue Decline to Disclose | ||||
| HF | Gordonmd Long Biased Master Fund LP | [2022-04-12] | 84.5 M | 202.0 M |
| Filed 2025-09-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Gordonmd PE Fund LP | [2022-04-12] | 0.7 M | 96.0 M |
| Filed 2021-10-07 (D) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $20,000 · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 7 | 322.3 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 7 | 322.3 |
| By Discretionary | ||
| Discretionary | 7 | 322.3 |
| Non-Discretionary | 0 | 0.0 |
| Total | 7 | 322.3 |
| By Non-United States Persons | ||
| Non-United States Persons | 6.7 | |
| United States Persons | 315.5 | |
| Total | 7 | 322.3 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Tyler Stowater | Executive Officer | 58 | 3 | |
| Steve Kirby | Executive Officer | 43 | 3 | |
| Sandy Horst | Executive Officer | 21 | 3 | |
| Nikole Mulder | Executive Officer | 18 | 3 | |
| Jon Kirby | Executive Officer | 16 | 3 | |
| LLC Bluestem Capital Company | Executive Officer | 10 | 3 | |
| Andrew Doshier | Executive Officer | 6 | 3 | |
| Gordonmd Global Investments LP | Executive Officer | 7 | 2 | |
| Gordonmd Pe Fund II GP LLC | Executive Officer | 2 | 2 | |
| Gordonmd SPV Managing Member LLC | Executive Officer | 1 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002039349] | |
| 3 | [0002039349] | |
| SC 13G | [0002039349] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Gordonmd Global Investments LP | Kyverna Therapeutics Inc | [2025-11-17] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 2549000G7FOOABJP8C67 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Triatomic Management LP
✚
|
CA | 346.3 M |
|
Vedanta Management LP
✚
|
NY | 345.6 M |
|
Borderless Management LLC
✚
|
FL | 345.4 M |
|
Superstring Capital Management LP
✚
|
NY | 339.5 M |
|
North Run Capital LP
✚
|
MA | 334.5 M |
|
Opus Investment Management LLC
✚
|
NY | 331.9 M |
|
Wolf River Capital Management LLC
✚
|
TN | 328.7 M |
|
Talara Capital Management LLC
✚
|
NJ | 317.6 M |
|
Spring Mountain Capital LP
✚
|
NY | 310.9 M |
|
Coltrane Asset Management LP
✚
|
NY | 304.0 M |